No Data
No Data
Tourmaline Bio Management to Meet With Cantor Fitzgerald
Tourmaline Bio to Present at the Guggenheim Securities SMID Cap Biotech Conference
Tourmaline Bio Appoints Ridker to Scientific Advisory Board
Press Release: Tourmaline Strengthens Cardiovascular Scientific Advisory Board With Appointment of Dr. Paul M. Ridker
Jefferies Maintains Tourmaline Bio(TRML.US) With Buy Rating, Cuts Target Price to $64
Leerink Partners Maintains Tourmaline Bio(TRML.US) With Buy Rating, Maintains Target Price $49
Trytosaveabit : Larry Fink is a terrible awful person! Sad part it’s hard to trade any ticker that he don’t have a part of! He has been on a buying spree! I’ve seen at least 25 in last 24 hours! Prolly more that he has been buying!